Template:Dgfn2015 Mo 08:15 Glycocalyx im Glomerulus

From HOP house of papers
(Difference between revisions)
Jump to: navigation, search
m
 
Line 52: Line 52:
 
===Pathogenetische Bedeutung von Lipiden beim M. Fabry===
 
===Pathogenetische Bedeutung von Lipiden beim M. Fabry===
 
[http://nephrologie.conference2web.com/users/7606 Porubsky-S]
 
[http://nephrologie.conference2web.com/users/7606 Porubsky-S]
 +
 +
vdgp 1950 scriba 34 221 nicht im pubmed. nicht im web. muß man kopieren gehen.
 +
 +
 +
{{tp|p=13536474|t=1958. The renal lesion in angiokeratoma corporis diffusum |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=13536474&pmc=2028866&ti=The%20renal%20lesion%20in%20angiokeratoma%20corporis%20diffusum|usr=}}
 +
{{utp|p=14007664|t=1962. Angiokeratoma corporis diffusum  A clinical study of eight affected families |pdf=http://qjmed.oxfordjournals.org/content/31/2/177.full-text.pdf|usr=}}
 +
{{tp|p=14081947|t=1963. FABRY S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID |pdf=http://www.jbc.org/content/238/9/PC3148.full.pdf|usr=}}
 +
{{tp|p=22875802|t=2012. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells |pdf=http://www.jimmunol.org/content/189/6/3007.full.pdf|usr=}}
 +
{{tp|p=17372206|t=2007. Normal development and function of invariant natural killer T cells in mice with  isoglobotrihexosylceramide (iGb3) deficiency |pdf=http://www.pnas.org/content/104/14/5977.full.pdf|usr=}}
 +
{{tp|p=24909663|t=2014. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure |pdf=http://onlinelibrary.wiley.com/doi/10.1002/path.4388/epdf|usr=}}
 +
{{tp|p=24992926|t=2014. Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry disease |pdf=http://link.springer.com/content/pdf/10.1007%2Fs00441-014-1922-9.pdf|usr=}}
 +
{{tp|p=24335674|t=2014. Globotriaosylceramide induces endothelial dysfunction in fabry disease |pdf=http://atvb.ahajournals.org/content/34/1/2.full.pdf|usr=}}
 +
{{tp|p=24158513|t=2014. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3 1 in fabry disease |pdf=http://atvb.ahajournals.org/content/34/1/81.full.pdf|usr=}}
 +
{{tp|p=20971723|t=2011. Globotriaosylceramide leads to K(Ca)3 1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease |pdf=http://cardiovascres.oxfordjournals.org/content/cardiovascres/89/2/290.full.pdf|usr=}}
 +
{{tp|p=23691056|t=2013. Dysregulated autophagy contributes to podocyte damage in Fabry s disease |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23691056&pmc=3656911&ti=Dysregulated%20autophagy%20contributes%20to%20podocyte%20damage%20in%20Fabry%20s%20disease|usr=}}
 +
{{utp|p=24239767|t=2014. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses |pdf=http://www.sciencedirect.com/science/article/pii/S1388198113002461|usr=}}
 +
{{tp|p=20504837|t=2011. Globotriaosylsphingosine actions on human glomerular podocytes: implications for  Fabry nephropathy |pdf=http://ndt.oxfordjournals.org/content/26/6/1797.full.pdf|usr=}}
 +
{{tp|p=26291612|t=2015. Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=26291612&pmc=4546309&ti=Epithelial-Mesenchymal%20Transition%20in%20Kidney%20Tubular%20Epithelial%20Cells%20Induced%20by%20Globotriaosylsphingosine%20and%20Globotriaosylceramide|usr=}}
 +
{{utp|p=23452955|t=2013. Fabry disease peripheral blood immune cells release inflammatory cytokines: role  of globotriaosylceramide |pdf=http://www.sciencedirect.com/science/article/pii/S1096719213000462|usr=}}
 +
{{tp|p=9122231|t=1997. alpha-Galactosidase A deficient mice: a model of Fabry disease |pdf=http://www.pnas.org/content/94/6/2540.full.pdf|usr=}}
 +
{{tp|p=10339603|t=1999. Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=10339603&pmc=26897&ti=Aging%20accentuates%20and%20bone%20marrow%20transplantation%20ameliorates%20metabolic%20defects%20in%20Fabry%20disease%20mice|usr=}}
 +
{{tp|p=20961863|t=2011. Increased globotriaosylceramide levels in a transgenic mouse expressing human alpha1,4-galactosyltransferase and a mouse model for treating Fabry disease |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=20961863&pmc=3031308&ti=Increased%20globotriaosylceramide%20levels%20in%20a%20transgenic%20mouse%20expressing%20human%20alpha1,4-galactosyltransferase%20and%20a%20mouse%20model%20for%20treating%20Fabry%20disease|usr=}}
 +
{{tp|p=24094090|t=2013. A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis |pdf=http://www.biochemj.org/content/ppbiochemj/456/3/373.full.pdf|usr=}}
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 +
 
folgt.
 
folgt.

Latest revision as of 08:59, 23 September 2015

Contents

Glycocalyx im Glomerulus

What is the role of the endothelial glycocalyx in renal diseases?

Rabelink T

Journal article, free access
GET 2015. A microscopic view on the renal endothelial glycocalyx Extract PDF direct

jvascres 2009 megens this reference does not exist.

Journal article, free access
GET 2013. Glycopolymer probes of signal transduction Extract PDF direct
Journal Paper, restricted access
GET 2014. Demystifying heparan sulfate-protein interactions Extract PDF direct
Journal article, free access
GET 2007. Emerging glycomics technologies Extract PDF direct
Journal article, free access
GET 2013. Glomerular endothelial surface layer acts as a barrier against albumin filtration Extract PDF direct
Journal article, free access
GET 2006. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium Extract PDF direct
Journal article, free access
GET 2006. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells Extract PDF direct
Journal article, free access
GET 2009. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb Extract PDF direct
Journal Paper, restricted access
GET 2011. The glomerular endothelial cell coat is essential for glomerular filtration Extract PDF direct

submitted/notavailable nrn 2015 rabelink

Journal article, free access
GET 2008. Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking Extract PDF direct
Journal article, free access
GET 2014. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis Extract PDF direct
Journal Paper, restricted access
GET 2014. Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo Extract PDF direct
Journal article, free access
GET 2007. Heparanase in glomerular diseases Extract PDF direct
Journal article, free access
GET 2012. Heparanase is essential for the development of diabetic nephropathy in mice Extract PDF direct
Weblink noncommercial paper pending
Atrasentan x Heparanase
Weblink noncommercial '
Glycoren consortium

Rolle von Lipiden an der Schlitzmembran des glomerulären Filters

Hagmann-H

Journal article, free access
GET 2009. Lipid-protein interactions along the slit diaphragm of podocytes Extract PDF direct
Journal article, free access
GET 2006. Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels Extract PDF direct
Journal article, free access
GET 2013. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex Extract PDF direct
Journal article, free access
GET 2013. Cyclodextrin protects podocytes in diabetic kidney disease Extract PDF direct
Journal article, free access
GET 2014. Lipid biology of the podocyte--new perspectives offer new opportunities Extract PDF direct
Journal article, free access
GET 2014. Breaking the chain at the membrane: paraoxonase 2 counteracts lipid peroxidation at the plasma membrane Extract PDF direct

The endothelial glycocalyx is a protective barrier against salt-induced vascular - Inflammation

Kusche-Vihrog-K


Dieser Webcast ist noch nicht verfügbar. Kann dann später die refs prüfen.

???jct 2010/2013 ?fasib

Journal article, free access
GET 2014. Feedforward activation of endothelial ENaC by high sodium Extract PDF direct

???nrn 2014 ??werneck/wernoch ???j c... hypertens 2013 ?jyggle ???pflügers a 2011 ??jyggle ejp 2011 oberleithner

Pathogenetische Bedeutung von Lipiden beim M. Fabry

Porubsky-S

vdgp 1950 scriba 34 221 nicht im pubmed. nicht im web. muß man kopieren gehen.


Journal article, free access
GET 1958. The renal lesion in angiokeratoma corporis diffusum Extract PDF direct
Journal Paper, restricted access
GET 1962. Angiokeratoma corporis diffusum A clinical study of eight affected families Extract PDF direct
Journal article, free access
GET 1963. FABRY S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID Extract PDF direct
Journal article, free access
GET 2012. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells Extract PDF direct
Journal article, free access
GET 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency Extract PDF direct
Journal article, free access
GET 2014. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure Extract PDF direct
Journal article, free access
GET 2014. Depletion of globosides and isoglobosides fully reverts the morphologic phenotype of Fabry disease Extract PDF direct
Journal article, free access
GET 2014. Globotriaosylceramide induces endothelial dysfunction in fabry disease Extract PDF direct
Journal article, free access
GET 2014. Globotriaosylceramide induces lysosomal degradation of endothelial KCa3 1 in fabry disease Extract PDF direct
Journal article, free access
GET 2011. Globotriaosylceramide leads to K(Ca)3 1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease Extract PDF direct
Journal article, free access
GET 2013. Dysregulated autophagy contributes to podocyte damage in Fabry s disease Extract PDF direct
Journal Paper, restricted access
GET 2014. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses Extract PDF direct
Journal article, free access
GET 2011. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy Extract PDF direct
Journal article, free access
GET 2015. Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide Extract PDF direct
Journal Paper, restricted access
GET 2013. Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide Extract PDF direct
Journal article, free access
GET 1997. alpha-Galactosidase A deficient mice: a model of Fabry disease Extract PDF direct
Journal article, free access
GET 1999. Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice Extract PDF direct
Journal article, free access
GET 2011. Increased globotriaosylceramide levels in a transgenic mouse expressing human alpha1,4-galactosyltransferase and a mouse model for treating Fabry disease Extract PDF direct
Journal article, free access
GET 2013. A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis Extract PDF direct
















folgt.

Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis